Cargando…
Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy
Multifocal motor neuropathy (MMN) is a rare disease with a prevalence of less than 1 per 100,000 people. Intravenous immunoglobulin (IVIG) therapy, performed for a long-term period, has been demonstrated able to improve the clinical picture of MMN patients, ameliorating motor symptoms and/or prevent...
Autores principales: | Gentile, Luca, Russo, Massimo, Rodolico, Carmelo, Arimatea, Ilenia, Vita, Giuseppe, Toscano, Antonio, Mazzeo, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080704/ https://www.ncbi.nlm.nih.gov/pubmed/33911162 http://dx.doi.org/10.1038/s41598-021-88711-9 |
Ejemplares similares
-
Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years
por: Gentile, L., et al.
Publicado: (2020) -
Intravenous Immunoglobulin Treatment in Multifocal Motor Neuropathy
por: van der Pol, W.-Ludo, et al.
Publicado: (2010) -
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy
por: Gentile, Luca, et al.
Publicado: (2021) -
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis
por: Vita, Gian Luca, et al.
Publicado: (2020) -
Pattern of muscle strength improvement after intravenous immunoglobulin therapy in multifocal motor neuropathy
por: Bakers, Jaap N.E., et al.
Publicado: (2021)